Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Whoosh Wellness vs Wisp

Whoosh Wellness
Graded #248

Lower grade

vs+10.900000000000006
Wisp
Graded #59

Higher grade

The verdict

Wisp takes it — 75/100 to 64.1/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +31
52
83
Dose & formulationWisp +11
77
88
Clinical oversightWisp +2
80
82
Labs & monitoringEven
53
53
FulfillmentWhoosh Wellness +10
76
66
Contract termsWisp +22
33
55
Whoosh Wellness · left barWisp · right bar

The numbers

MetricWhoosh WellnessWisp
WeighScore64.1/10075/100
GradeCC
Scorecard rank#248#59
Semaglutide$187/mo (compounded)$225/mo (compounded oral)
Tirzepatide$235/mo (compounded)$99/mo (starting dose, brand-name)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Whoosh Wellness

Graded #248 · C

Strengths

  • All-inclusive pricing — physician review, supplies, and free shipping bundled into one monthly price; no charge until prescribed
  • Compounded semaglutide from $187/mo and tirzepatide from $235/mo (lower on 3- and 6-month plans)
  • Pharmacy-grade 503A/503B compounding with third-party batch testing; supplies (syringes, swabs) included
  • Physician-led with 24/7 ongoing provider access and monthly check-ins; also offers sermorelin, NAD+ and glutathione

Where it loses points

  • Best rates require a 3- or 6-month commitment; month-to-month starts at $187 (semaglutide) / $235 (tirzepatide)
  • Doesn't name its specific compounding pharmacy partners
  • No explicit state-coverage list or LegitScript certification shown on the site
  • Compounded GLP-1s are not FDA-approved
Wisp

Graded #59 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard